- Home
- GXAI vs IMCC Comparison
GXAI vs IMCC Comparison
Compare GXAI & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- IMCC
- Stock Information
- Founded
- GXAI 2021
- IMCC 1980
- Country
- GXAI United States
- IMCC Israel
- Employees
- GXAI N/A
- IMCC N/A
- Industry
- GXAI
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- GXAI
- IMCC Health Care
- Exchange
- GXAI Nasdaq
- IMCC Nasdaq
- Market Cap
- GXAI 13.0M
- IMCC 10.4M
- IPO Year
- GXAI 2023
- IMCC N/A
- Fundamental
- Price
- GXAI $1.36
- IMCC $1.34
- Analyst Decision
- GXAI
- IMCC
- Analyst Count
- GXAI 0
- IMCC 0
- Target Price
- GXAI N/A
- IMCC N/A
- AVG Volume (30 Days)
- GXAI 197.6K
- IMCC 1.3M
- Earning Date
- GXAI 11-14-2025
- IMCC 11-13-2025
- Dividend Yield
- GXAI N/A
- IMCC N/A
- EPS Growth
- GXAI N/A
- IMCC N/A
- EPS
- GXAI N/A
- IMCC N/A
- Revenue
- GXAI $198,711.00
- IMCC $38,430,631.00
- Revenue This Year
- GXAI N/A
- IMCC $47.12
- Revenue Next Year
- GXAI N/A
- IMCC $12.83
- P/E Ratio
- GXAI N/A
- IMCC N/A
- Revenue Growth
- GXAI 72158.55
- IMCC 5.08
- 52 Week Low
- GXAI $1.00
- IMCC $1.20
- 52 Week High
- GXAI $7.50
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- GXAI 34.66
- IMCC 31.38
- Support Level
- GXAI $1.45
- IMCC $1.21
- Resistance Level
- GXAI $1.54
- IMCC $1.39
- Average True Range (ATR)
- GXAI 0.12
- IMCC 0.21
- MACD
- GXAI -0.04
- IMCC -0.02
- Stochastic Oscillator
- GXAI 21.12
- IMCC 9.32
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.